How to Get Started & What to Do Each Day
The labs listed below are accessible, affordable, and reported to have been successfully used by people self-administering the fenbendazole protocol. Not medical advice.
Good planning makes any long-term health routine easier to manage. Staying organized from the beginning can reduce stress, help you recognize changes over time, and provide useful information to discuss with your healthcare provider.
Before beginning any medication or supplement, discuss it with your physician or another qualified healthcare professional. If you and your provider decide to move forward, follow the dosage and schedule they recommend. Taking medication consistently and exactly as directed helps reduce the risk of dosing errors.
Keep a Daily Journal
Purchase a notebook or create a digital journal dedicated to your health routine. If you expect to follow a protocol for several months, keeping detailed records can help you monitor your progress and identify trends that might otherwise go unnoticed.
Consider recording the following information each day:
Protocol
Days on:
Days off:
Medication
Brand:
Date:
Time taken:
Amount:
Form (powder, paste, capsule, etc.):
Food & Drink
Before taking medication:
During:
After:
Supplements
If you are taking vitamins or other supplements, record:
Supplement name:
Brand:
Amount:
Time taken:
Taken with food?
Consumed with or added to:
Water Intake
Staying hydrated is important for overall health. Record:
Total glasses of water consumed each day
Times you drank water
Water consumed with meals
Water consumed with medication
Water consumed with supplements
Daily Health Report
Take a few minutes each day to write down how you feel.
How do I feel today compared to yesterday?
How do I feel compared to the first day?
What changes have I noticed?
Pain level:
Energy level:
Sleep quality:
Digestive symptoms:
Other observations:
Tracking Your Health
Some people and their healthcare providers use periodic laboratory testing to monitor general health while taking long-term medications. Depending on your individual circumstances, your provider may recommend tests that evaluate blood counts, liver function, kidney function, inflammation, or other biomarkers.
Examples include:
Complete Blood Count (CBC)
Comprehensive Metabolic Panel (CMP)
High-sensitivity C-reactive protein (hs-CRP)
Liver function testing
In many areas, certain laboratory tests can also be ordered directly through consumer laboratory services without a physician’s order, although availability varies by location.
Examples include:
Labcorp OnDemand
QuestHealth
Request A Test
Some services also offer access to specialty laboratory tests, including certain tumor marker tests, when appropriate and ordered.
Stay Organized
Your journal becomes a valuable record of your health over time. Recording symptoms, laboratory results, medications, supplements, and other observations creates a timeline that can help you and your healthcare provider evaluate how your body is responding and determine whether changes to your treatment plan are appropriate.
The more consistent your records, the more useful they become. Whether you continue your routine for several weeks or several months, you’ll have a detailed history to reference during future medical appointments and when reviewing your progress.
This is not medical advice. Please discuss all blood tests with your doctor before visiting any lab.
Lab blood tests
Cancer Antigen CA 19-9
Cancer Antigen CA 15-3
Amylase Isoenzymes
Cancer Antigen CA 125
Cancer Antigen CA 27.29
CEA (Carcinoembryonic Antigen)
The first five are tumor markers (proteins that certain cancers shed into the bloodstream), and the last one, amylase isoenzymes, is a source-identification test.
CA 19-9
A carbohydrate antigen most linked to pancreatic cancer, and also to bile duct, gallbladder, gastric, and colorectal cancers. Used for gauging prognosis, assessing whether a pancreatic tumor is likely resectable, and monitoring response to treatment. Two important quirks: anything obstructing the bile ducts (stones, cholangitis, even benign jaundice) can push it very high without cancer, and roughly 5–10% of people lack the Lewis blood group enzyme needed to make it at all, so their level stays low no matter what.
CA 15-3
A fragment of the MUC1 protein shed by breast cancer cells. It’s a monitoring marker for advanced or metastatic breast cancer — following whether treatment is working or disease is progressing. It’s usually normal in early-stage breast cancer, which is why it isn’t used for screening or diagnosis. Benign breast conditions, liver disease, and other cancers can also elevate it modestly.
CA 27.29
Also a MUC1 marker — essentially the same antigen as CA 15-3, detected with a different antibody. It serves the same purpose in breast cancer monitoring, and the two are largely interchangeable. Labs typically run one or the other; having both ordered is usually redundancy rather than two different pieces of information.
CA 125
The MUC16 protein, best known in epithelial ovarian cancer. It’s used to monitor treatment response and recurrence, and as one input (often alongside HE4 and imaging) when evaluating an ovarian or pelvic mass. It’s notably nonspecific in premenopausal women — endometriosis, fibroids, menstruation, pregnancy, pelvic infection — and rises with anything irritating the peritoneum or causing fluid buildup, including cirrhosis and heart failure. It’s more meaningful in postmenopausal women.
Amylase isoenzymes
This one answers a different question. Total amylase in blood comes mainly from two sources: the pancreas (P-type) and the salivary glands (S-type). Fractionating it tells you which. It’s ordered when amylase is elevated, but the cause isn’t obvious — to confirm a pancreatic source (pancreatitis, pancreatic duct obstruction) versus a salivary one (mumps, parotitis, heavy alcohol use, purging behaviors). It also identifies macroamylasemia, a harmless condition where amylase binds to an antibody and can’t be cleared by the kidneys, producing persistently high readings with no disease at all. Occasionally, certain lung and ovarian tumors produce salivary-type amylase ectopically, which is likely why it appears in a panel like this.
CEA (carcinoembryonic antigen)
A glycoprotein made abundantly by fetal gut tissue and normally present at very low levels in adults. It’s most associated with colorectal cancer but also rises in pancreatic, gastric, lung, breast, and medullary thyroid cancers. Its main real value is tracking: a baseline before surgery, then serial measurements afterward, where a rising trend can signal recurrence months before imaging does. It’s also raised by non-cancer things — smoking is a common one, along with cirrhosis, inflammatory bowel disease, pancreatitis, and COPD.
The framing that matters most: none of these are diagnostic on their own, and none are approved as screening tests for people without symptoms. They’re too easily raised by benign conditions and too often normal in early cancer. Their strength is in trends over time in someone with a known diagnosis, and as supporting evidence alongside imaging, exam findings, and ultimately tissue. A single elevated value is a prompt to look further, not an answer. Reference ranges also vary by lab and assay, so results should be compared against the range printed on your own report and ideally followed at the same lab.
Labcorp OnDemand - https://www.ondemand.labcorp.com/products www.labcorp.com
QuestHealth.com - https://www.questhealth.com/shop-tests www.questhealth.com/
Request A Test - https://requestatest.com/tests/search?criteria=cancer
https://requestatest.com/